https://medicaex.com/prnewswire/xspray-pharma-partners-with-eversana-for-the-u-s-launch-and-commercialization-of-its-lead-product-dasynoc-xs004-for-the-treatment-of-chronic-myeloid-leukemia-cml-and-acute-lymphatic-leukem/ 2023-02-24T12:12:24+00:00 https://medicaex.com/prnewswire/kubota-tractor-corporation-implements-syncron-for-streamlined-retail-inventory-management-and-exceptional-dealer-network-service/ 2023-02-24T09:12:27+00:00 https://medicaex.com/prnewswire/huichao-liang-an-expert-on-aids-combined-with-gynecological-oncology-receives-excellent-popular-science-worker-award/ 2023-02-24T09:12:15+00:00 https://medicaex.com/prnewswire/innovation-deficit-funds-for-neglected-diseases-like-tb-are-falling-short/ 2023-02-24T08:12:18+00:00 https://medicaex.com/prnewswire/keymed-and-lepu-biopharma-jointly-announce-global-exclusive-licence-agreement-with-astrazeneca-for-cmg901/ 2023-02-23T21:13:06+00:00 https://medicaex.com/prnewswire/lepu-biopharma-and-keymed-jointly-announces-global-exclusive-licence-agreement-with-astrazeneca-for-cmg901/ 2023-02-23T21:13:06+00:00 https://medicaex.com/prnewswire/dawn-health-partners-with-leading-pharmaceutical-company-to-transform-chronic-care/ 2023-02-23T14:14:50+00:00 https://medicaex.com/prnewswire/trip-com-group-aids-community-recovery-through-turkish-earthquake-relief-initiative/ 2023-02-23T14:14:50+00:00 https://medicaex.com/prnewswire/new-study-from-waltham-petcare-science-institute-part-of-mars-petcare-shows-cannabidiol-cbd-is-effective-at-reducing-stress-in-dog/ 2023-02-23T14:14:50+00:00 https://medicaex.com/prnewswire/renexxion-ireland-ltd-and-dr-falk-pharma-gmbh-announce-initiation-of-phase-ii-study-of-naronapride-in-patients-with-gastroparesis/ 2023-02-23T13:15:01+00:00 https://medicaex.com/prnewswire/mindray-revolutionizes-the-way-of-using-ultrasound-with-te-air-its-first-wireless-handheld-ultrasound-system/ 2023-02-23T13:14:56+00:00 https://medicaex.com/prnewswire/150th-anniversary-of-dr-hansens-discovery-of-m-leprae-is-opportunity-to-examine-past-present-and-future-of-leprosy/ 2023-02-23T13:14:49+00:00 https://medicaex.com/prnewswire/metabolon-to-offer-targeted-panels-and-assays-to-aid-in-dysregulated-glucose-status-and-related-research/ 2023-02-23T08:13:28+00:00 https://medicaex.com/prnewswire/ajinomoto-bio-pharma-services-successfully-develops-highly-functional-ancestral-rna-ligase/ 2023-02-23T08:13:22+00:00 https://medicaex.com/prnewswire/genscript-probio-and-rvac-medicines-announce-strategic-partnership-for-gmp-plasmid-dna-manufacturing-for-mrna-covid-19-vaccine-candidate/ 2023-02-23T07:12:24+00:00 https://medicaex.com/prnewswire/world-renowned-therapist-and-wellness-expert-marisa-peer-endorses-natural-prebiotic-kfibre-kfibre-pro-synbiotics-for-advanced-gut-health-management/ 2023-02-23T06:12:24+00:00 https://medicaex.com/prnewswire/eversana-consulting-named-a-top-ranked-consulting-firm-by-vault-across-asia-pacific/ 2023-02-22T16:12:17+00:00 https://medicaex.com/prnewswire/gilead-to-present-data-at-apasl-2023-on-effective-models-for-monitoring-and-treating-hepatitis-c-and-efficacy-of-antiviral-treatments-for-hiv-1-and-hbv-coinfected-adults/ 2023-02-22T14:12:56+00:00 https://medicaex.com/prnewswire/organizational-level-unified-and-vendor-neutral-enterprise-imaging-and-informatics-drive-effective-digital-transformation/ 2023-02-22T13:13:40+00:00 https://medicaex.com/prnewswire/synbio-tech-inc-and-cosmax-group-signed-an-exclusive-cooperation-agreement-to-jointly-expand-the-south-korean-probiotics-market/ 2023-02-22T13:13:40+00:00 https://medicaex.com/prnewswire/groundbreaking-clinical-trial-underway-to-improve-vision-in-individuals-with-advanced-retinitis-pigmentosa-rp/ 2023-02-22T12:14:45+00:00 https://medicaex.com/prnewswire/telix-collaboration-on-next-generation-urologic-oncology-theranostic-published-in-journal-of-nuclear-medicine/ 2023-02-22T12:14:45+00:00 https://medicaex.com/prnewswire/histosonics-announces-fda-approval-of-its-pivotal-ide-hope4kidney-trial/ 2023-02-22T12:14:39+00:00 https://medicaex.com/prnewswire/pharming-announces-first-patient-enrolled-in-pediatric-clinical-trial-of-leniolisib/ 2023-02-22T12:14:34+00:00 https://medicaex.com/prnewswire/chrysalis-advisory-and-trinetx-establish-a-strategic-collaboration-to-support-research-teams-across-australia-and-new-zealand/ 2023-02-22T12:14:34+00:00 https://medicaex.com/prnewswire/eluminex-biosciences-announces-completion-of-initial-enrollment-in-part-a-of-the-clarity-study-evaluating-a-human-recombinant-collagen-derived-rhciii-biosynthetic-cornea-eb-301/ 2023-02-21T13:12:26+00:00 https://medicaex.com/prnewswire/randomized-controlled-trial-backs-clinical-efficacy-of-lunit-ai-for-chest-x-ray/ 2023-02-21T12:13:04+00:00 https://medicaex.com/prnewswire/ansell-applauded-by-frost-sullivan-for-protecting-clinicians-and-patients-using-latex-free-gloves-and-its-market-leading-position/ 2023-02-21T12:12:39+00:00 https://medicaex.com/prnewswire/concept-medical-granted-investigational-device-exemption-ide-approval-for-their-magic-touch-sirolimus-coated-balloon-for-the-treatment-of-below-the-knee-btk-arterial-disease/ 2023-02-21T09:12:36+00:00 https://medicaex.com/prnewswire/celltrion-and-liscure-biosciences-announce-strategic-collaboration-to-develop-novel-microbiome-treatment-for-parkinsons-disease/ 2023-02-21T08:12:34+00:00 https://medicaex.com/prnewswire/nippon-express-singapore-receives-iata-ceiv-pharma-certification-for-changi-international-airport-facility/ 2023-02-21T07:12:18+00:00 https://medicaex.com/prnewswire/daewoong-pharmaceutical-reaches-sales-of-krw-1-16-trillion-in-2022-fexuclue-leads-the-highest-revenue/ 2023-02-21T06:13:35+00:00 https://medicaex.com/prnewswire/mindlax-revolutionizes-sleep-solutions-with-vibroacoustic-sleeping-mat/ 2023-02-21T06:12:19+00:00 https://medicaex.com/prnewswire/gracell-biotechnologies-announces-china-nmpa-clearance-for-ind-application-for-phase-1-2-clinical-trial-of-fastcar-t-gc012f-for-treatment-of-relapsed-refractory-multiple-myeloma/ 2023-02-21T02:12:55+00:00 https://medicaex.com/prnewswire/ascletis-presented-positive-phase-i-clinical-data-for-broad-spectrum-antiviral-double-prodrug-asc10-at-croi-2023/ 2023-02-21T01:12:49+00:00 https://medicaex.com/prnewswire/vista-eye-specialist-to-showcase-latest-eye-care-technology/ 2023-02-21T00:12:22+00:00 https://medicaex.com/prnewswire/kintor-pharma-announces-positive-top-line-u-s-phase-i-trial-results-of-gt20029-the-worlds-first-topical-use-protac-compound/ 2023-02-20T23:12:28+00:00 https://medicaex.com/prnewswire/ts7000dv-surgical-table-first-integrated-table-motion-for-the-da-vinci-xi-surgical-system-appears-at-device-technologies-asia-training-center/ 2023-02-20T16:15:22+00:00 https://medicaex.com/prnewswire/qilian-international-holding-group-ltd-declares-special-cash-dividends-to-shareholders/ 2023-02-20T16:15:18+00:00 https://medicaex.com/prnewswire/terumo-blood-and-cell-technologies-imugard-platelet-pooling-set-cleared-by-fda/ 2023-02-20T15:12:18+00:00 https://medicaex.com/prnewswire/angel-yeast-announces-plans-to-beef-up-supply-and-innovation-capabilities-in-response-to-increasing-global-yeast-demand/ 2023-02-20T13:12:36+00:00 https://medicaex.com/prnewswire/duoning-enters-partnership-with-bioaces-to-expand-cell-analysis-portfolio/ 2023-02-20T13:12:36+00:00 https://medicaex.com/prnewswire/dalton-announces-major-expansion-in-commercial-sterile-manufacturing-capacity/ 2023-02-20T04:13:33+00:00 https://medicaex.com/prnewswire/immuno-cure-kick-off-phase-i-clinical-trial-in-shenzhen/ 2023-02-20T01:12:18+00:00 https://medicaex.com/prnewswire/sk-bioscience-introduces-new-partnership-model-to-establish-regional-vaccine-hubs/ 2023-02-20T01:12:15+00:00 https://medicaex.com/prnewswire/hanall-biopharma-invests-in-interon-to-seek-collaboration-opportunities/ 2023-02-19T23:12:22+00:00 https://medicaex.com/prnewswire/biosyngen-has-obtained-fda-ind-clearance-of-brg01-for-phase-i-ii-clinical-trials-against-nasopharyngeal-cancer/ 2023-02-17T16:12:17+00:00 https://medicaex.com/prnewswire/aqilion-announces-pre-clinical-licensing-and-strategic-research-collaboration-agreement-with-merck/ 2023-02-17T15:12:19+00:00 https://medicaex.com/prnewswire/tianlong-new-product-panall-8000-shines-at-medlab-middle-east-2023/ 2023-02-17T13:12:26+00:00 https://medicaex.com/prnewswire/pharming-provides-update-on-ema-regulatory-review-of-leniolisib-for-apds-in-europe/ 2023-02-17T13:12:19+00:00 https://medicaex.com/prnewswire/farrer-park-hospital-launches-clinical-collaboration-with-arc-hospitals/ 2023-02-17T13:12:18+00:00 https://medicaex.com/prnewswire/novavax-nuvaxovid-covid-19-vaccine-approved-in-south-korea-as-an-adult-booster/ 2023-02-17T12:12:18+00:00 https://medicaex.com/prnewswire/111-inc-hosts-hua-medicine-launches-first-official-flagship-store/ 2023-02-17T12:12:16+00:00 https://medicaex.com/prnewswire/usanas-malaysia-market-awarded-for-facial-serum/ 2023-02-17T04:12:09+00:00 https://medicaex.com/prnewswire/boan-biotechs-investigational-long-acting-anti-il-4r%ce%b1-antibody-ba2101-administered-for-first-patient-in-phase-i-clinical-trial/ 2023-02-17T00:12:14+00:00 https://medicaex.com/prnewswire/wuxi-apptec-named-industry-mover-in-sp-global-sustainability-yearbook-2023/ 2023-02-16T21:12:17+00:00 https://medicaex.com/prnewswire/innovent-announces-first-patient-dosed-in-a-phase-3-clinical-trial-clear-of-picankibart-anti-il23p19-monoclonal-antibody-in-patients-with-moderate-to-severe-plaque-psoriasis/ 2023-02-16T19:12:17+00:00 https://medicaex.com/prnewswire/cgtn-chinas-covid-19-vaccines-proven-safe-effective-by-trials-and-data/ 2023-02-16T14:12:20+00:00 https://medicaex.com/prnewswire/bioved-pharmaceuticals-inc-announces-the-launch-of-its-proprietary-natural-products-for-animal-health-with-its-shwan-ayurved-science/ 2023-02-16T12:12:18+00:00 https://medicaex.com/prnewswire/h-advisors-public-affairs-powered-by-havas-health-you-to-launch-fully-integrated-u-k-eu-u-s-public-affairs-practice/ 2023-02-16T12:12:13+00:00 https://medicaex.com/prnewswire/oral-presentation-at-apasl-annual-meeting-2023-demonstrates-asc22-a-subcutaneous-pd-l1-antibody-can-achieve-functional-cure-of-chronic-hepatitis-b/ 2023-02-16T10:12:14+00:00 https://medicaex.com/prnewswire/anpac-bio-medical-science-acquires-gisn-hk-limited-a-technical-solution-and-outsourcing-consulting-services-provider/ 2023-02-16T07:12:15+00:00 https://medicaex.com/prnewswire/internationally-renowned-orthopaedic-surgeon-thought-leaders-join-formus-labs-clinical-advisory-board/ 2023-02-16T06:12:14+00:00 https://medicaex.com/prnewswire/flagship-biosciences-applauded-by-frost-sullivan-for-changing-biomarker-analysis-to-find-biomarkers-that-aid-drug-development-and-diagnostics/ 2023-02-16T00:12:14+00:00 https://medicaex.com/prnewswire/syqe-medical-announces-agreement-with-israeli-ministry-of-defence-to-provide-the-syqeair-technology-to-veterans/ 2023-02-16T00:12:14+00:00 https://medicaex.com/prnewswire/nona-biosciences-enters-into-hcab-based-antibody-discovery-collaboration-agreement-with-mythic-therapeutics/ 2023-02-15T22:12:28+00:00 https://medicaex.com/prnewswire/syntach-ab-announces-partnership-with-meditrial-cro-to-drive-clinical-development-of-groundbreaking-cardiac-support-system/ 2023-02-15T20:12:19+00:00 https://medicaex.com/prnewswire/innovent-announces-first-participant-dosed-in-phase-2-study-of-ibi311-anti-igf-1r-monoclonal-antibody-in-patients-with-thyroid-associated-ophthalmopathy/ 2023-02-15T17:12:14+00:00 https://medicaex.com/prnewswire/acurabio-expands-cgmp-plasmid-dna-cdmo-services-with-cytivas-latest-single-use-purification-technology-to-alleviate-supply-constraints-for-mrna-and-cell-gene-therapies-2/ 2023-02-15T13:12:22+00:00 https://medicaex.com/prnewswire/lunit-and-agfa-healthcare-bring-breast-imaging-ai-solution-to-dubai-academic-health-corporation-dahc-dubai-hospital/ 2023-02-15T13:12:19+00:00 https://medicaex.com/prnewswire/henlius-announces-u-s-fda-acceptance-of-biologics-license-application-for-proposed-biosimilar-trastuzumab-hlx02/ 2023-02-15T09:12:16+00:00 https://medicaex.com/prnewswire/towards-inexpensive-and-highly-conductive-anion-exchange-membranes-wpi-mana/ 2023-02-15T07:12:08+00:00 https://medicaex.com/prnewswire/armis-scores-as-a-top-performer-in-the-2023-best-in-klas-software-services-report/ 2023-02-15T06:12:18+00:00 https://medicaex.com/prnewswire/point-of-care-ultrasound-training-in-under-resourced-region-improves-physician-knowledge/ 2023-02-15T06:12:15+00:00 https://medicaex.com/prnewswire/us-based-cobra-diagnostic-prostate-cancer-trial-reaches-recruitment-target/ 2023-02-15T02:12:21+00:00 https://medicaex.com/prnewswire/anpac-bio-medical-science-enters-into-definitive-agreement-to-make-another-acquisition-to-significantly-expand-scope-of-business-in-the-u-s/ 2023-02-15T00:12:18+00:00 https://medicaex.com/prnewswire/cgtn-china-protects-lives-shares-experience-in-global-covid-19-fight/ 2023-02-14T23:12:43+00:00 https://medicaex.com/prnewswire/technoderma-medicines-initiates-tdm-180935-atopic-dermatitis-clinical-program-with-phase-1-dose-escalation-trial/ 2023-02-14T21:12:25+00:00 https://medicaex.com/prnewswire/immvira-clinical-snapshot-intratumoral-injected-ov-mvr-t3011-it-monotherapy-achieved-median-pfs-of-12-9-months-on-treatment-of-melanoma/ 2023-02-14T20:12:21+00:00 https://medicaex.com/prnewswire/completion-of-the-first-batch-of-subject-enrollment-for-the-phase-i-clinical-trial-of-the-companys-novel-adjuvanted-recombinant-shingles-vaccine-rec610/ 2023-02-14T17:12:15+00:00 https://medicaex.com/prnewswire/eurofins-discovery-collaborating-with-invasight-on-cancer-therapies/ 2023-02-14T17:12:14+00:00 https://medicaex.com/prnewswire/revir-therapeutics-and-asieris-pharmaceuticals-enter-into-agreement-to-discover-oncology-therapeutics-based-on-revirs-comprehensive-approach-to-rna-targeted-technologies/ 2023-02-14T16:12:26+00:00 https://medicaex.com/prnewswire/waterdrop-ceo-peng-shen-elected-as-a-member-of-the-school-affairs-council-of-hku-business-school/ 2023-02-14T14:12:12+00:00 https://medicaex.com/prnewswire/cj-fnt-was-globally-launched-to-become-a-total-solutions-provider-in-the-food-nutrition-market/ 2023-02-14T14:12:12+00:00 https://medicaex.com/prnewswire/complete-genomics-drops-genome-sequencing-price-to-sub-100-at-agbt-general-meeting/ 2023-02-14T13:12:18+00:00 https://medicaex.com/prnewswire/b-dot-medical-to-install-ultra-compact-proton-therapy-system-at-thammasat-university-in-thailand/ 2023-02-14T13:12:15+00:00 https://medicaex.com/prnewswire/athachi-group-showcases-trust-nature-initiative-to-union-ministers-the-trust-nature-philosophy-is-akin-to-yoga-to-the-world/ 2023-02-14T04:12:13+00:00 https://medicaex.com/prnewswire/boan-biotechs-investigational-anti-cd25-antibody-ba1106-administered-for-first-patient-in-phase-i-clinical-trial/ 2023-02-14T03:12:16+00:00 https://medicaex.com/prnewswire/havas-health-you-appoints-internationally-recognized-creative-alex-okada-as-chief-creative-officer-of-havas-lynx-group/ 2023-02-13T15:12:14+00:00 https://medicaex.com/prnewswire/mount-elizabeth-hospital-first-in-southeast-asia-to-acquire-naeotom-alpha-from-siemens-healthineers/ 2023-02-13T14:12:23+00:00 https://medicaex.com/prnewswire/j-ints-bio-oral-tki-jin-a04-poster-presentation-of-her2-exon20-insertion-mutation-in-nsclc/ 2023-02-13T13:12:22+00:00 https://medicaex.com/prnewswire/shamir-optics-selects-inuitives-nu4000-to-power-its-next-generation-digital-measurement-device/ 2023-02-13T13:12:19+00:00 https://medicaex.com/prnewswire/vmade-launched-cooperation-with-fulgent-life-to-build-a-cross-border-saas-and-payment-integration-solution-for-private-growth/ 2023-02-13T13:12:11+00:00 https://medicaex.com/prnewswire/hinova-receives-fda-proceed-authorization-for-its-ind-application-for-hp518-an-orally-bioavailable-chimeric-degrader-targeting-androgen-receptor-for-prostate-cancer-treatment-2/ 2023-02-13T12:12:21+00:00 https://medicaex.com/prnewswire/nippon-express-obtains-gdp-certification-of-compliance-with-who-standards-at-2-domestic-locations-west-japan-pharmaceutical-center-and-kyushu-pharmaceutical-center/ 2023-02-13T07:12:14+00:00 https://medicaex.com/prnewswire/suvoda-introduces-extensible-software-platform-bringing-proven-tech-innovation-to-clinical-trial-management/ 2023-02-13T06:12:18+00:00 https://medicaex.com/prnewswire/ncsm-doctoroncall-join-forces-to-promote-free-covid-19-vaccination-and-booster-doses-including-on-site-and-house-to-house/ 2023-02-13T01:12:16+00:00 https://medicaex.com/prnewswire/copan-diagnostics-announces-leadership-change/ 2023-02-13T00:12:20+00:00 https://medicaex.com/prnewswire/everest-medicines-announces-south-korea-grants-fast-track-review-designation-to-nefecon-for-the-treatment-of-primary-iga-nephropathy/ 2023-02-13T00:12:15+00:00 https://medicaex.com/prnewswire/rewe-international-will-rely-on-korbers-warehouse-management-system/ 2023-02-13T00:12:15+00:00 https://medicaex.com/prnewswire/looking-back-on-three-years-of-covid-19-in-china/ 2023-02-12T14:12:13+00:00 https://medicaex.com/prnewswire/record-short-videos-to-assess-parkinsons-disease-nervtexs-first-in-class-ai-based-movement-dysfunction-assessment-software-medical-device-approved/ 2023-02-11T00:12:30+00:00 https://medicaex.com/prnewswire/cgtn-reflecting-on-chinas-three-year-covid-battle-in-through-the-storm/ 2023-02-10T15:12:15+00:00 https://medicaex.com/prnewswire/tavneos-avacopan-approved-in-australia-for-the-treatment-of-anca-associated-vasculitis/ 2023-02-10T13:12:21+00:00 https://medicaex.com/prnewswire/hinova-receives-fda-proceed-authorization-for-its-ind-application-for-hp518-an-orally-bioavailable-chimeric-degrader-targeting-androgen-receptor-for-prostate-cancer-treatment/ 2023-02-10T12:12:25+00:00 https://medicaex.com/prnewswire/hugel-achieved-record-high-revenue-and-operating-profit/ 2023-02-10T12:12:18+00:00 https://medicaex.com/prnewswire/guardant-health-to-integrate-lunits-ai-based-scoring-algorithm-for-pd-l1-into-its-portfolio-to-enhance-cancer-biomarker-detection/ 2023-02-10T09:12:22+00:00 https://medicaex.com/prnewswire/first-prescription-for-cosela-trilaciclib-issued-in-china/ 2023-02-10T09:12:17+00:00 https://medicaex.com/prnewswire/leveraging-digital-technologies-can-help-grow-strong-and-sustainable-communities/ 2023-02-10T09:12:12+00:00 https://medicaex.com/prnewswire/anpac-bio-medical-science-enters-into-definitive-agreement-to-acquire-fresh2-ecommerce-inc-a-b2b-asian-food-e-commerce-platform/ 2023-02-10T06:12:13+00:00 https://medicaex.com/prnewswire/inmagene-receives-ind-clearance-for-img-008-a-long-acting-il-36r-mab/ 2023-02-10T05:12:22+00:00 https://medicaex.com/prnewswire/ground-breaking-results-in-phase-2-scleroderma-study-by-certa-therapeutics-demonstrates-improvement-in-more-than-60-of-patients/ 2023-02-10T01:12:21+00:00 https://medicaex.com/prnewswire/dna-data-company-asa-ren-raised-an-oversubscribed-us8-15m-to-build-an-indonesia-population-dna-database/ 2023-02-10T01:12:15+00:00 https://medicaex.com/prnewswire/gc-biopharma-receives-who-pre-qualification-for-filling-and-finish-plant-in-ochang-south-korea/ 2023-02-09T23:12:15+00:00 https://medicaex.com/prnewswire/acurabio-expands-cgmp-plasmid-dna-cdmo-services-with-cytivas-latest-single-use-purification-technology-to-alleviate-supply-constraints-for-mrna-and-cell-gene-therapies/ 2023-02-09T21:12:17+00:00 https://medicaex.com/prnewswire/novotech-awarded-by-frost-sullivan-for-global-biotech-clinical-trials-excellence-in-apac/ 2023-02-09T19:12:20+00:00 https://medicaex.com/prnewswire/daewoong-pharmaceutical-begins-the-first-administration-of-the-bersiporocin-new-treatment-for-idiopathic-pulmonary-fibrosis-as-phase-ii-clinical-trial/ 2023-02-09T14:12:25+00:00 https://medicaex.com/prnewswire/halucenex-life-sciences-inc-targets-australian-market-following-landmark-tga-decision/ 2023-02-09T14:12:18+00:00 https://medicaex.com/prnewswire/gracell-biotechnologies-announces-fda-clearance-of-the-ind-application-for-phase-1b-2-clinical-trial-of-fastcar-t-gc012f-for-the-treatment-of-relapsed-refractory-multiple-myeloma/ 2023-02-09T13:12:25+00:00 https://medicaex.com/prnewswire/summit-healthcare-acquisition-corp-and-ys-biopharma-announce-effectiveness-of-registration-statement-and-extraordinary-general-meeting-date-for-proposed-business-combination/ 2023-02-09T13:12:16+00:00 https://medicaex.com/prnewswire/summit-healthcare-acquisition-corp-and-ys-biopharma-announce-effectiveness-of-registration-statement-and-extraordinary-general-meeting-date-for-proposed-business-combination-2/ 2023-02-09T13:12:16+00:00 https://medicaex.com/prnewswire/meihua-international-medical-technologies-co-explores-application-of-chatgpt-technologies-to-develop-online-ai-health-consultation-services/ 2023-02-09T10:12:18+00:00 https://medicaex.com/prnewswire/dizal-announces-china-cde-acceptance-of-new-drug-application-for-sunvozertinib-for-platinum-pretreated-nsclc-patients-with-egfr-exon20ins-mutations/ 2023-02-09T08:12:20+00:00 https://medicaex.com/prnewswire/the-national-cancer-society-of-malaysia-ncsm-msd-and-doctoroncall-collaborate-in-conjunction-with-world-cancer-day-2023-to-offer-affordable-health-screenings-to-members-of-the-public/ 2023-02-09T01:12:26+00:00 https://medicaex.com/prnewswire/sk-bioscience-announces-the-largest-investment-ever-to-establish-songdo-global-research-process-development-center/ 2023-02-09T01:12:26+00:00 https://medicaex.com/prnewswire/infectious-disease-specialist-dr-regis-a-vilchez-is-appointed-cmo-of-micurx-pharmaceuticals-inc/ 2023-02-09T00:12:15+00:00 https://medicaex.com/prnewswire/orion-health-reinforces-security-credentials-with-hitrust-and-directtrust-accreditations/ 2023-02-09T00:12:15+00:00 https://medicaex.com/prnewswire/the-worlds-oldest-living-lab-rat-points-the-way-to-rejuvenation/ 2023-02-08T22:12:19+00:00 https://medicaex.com/prnewswire/sonire-announces-first-patient-enrolled-in-randomized-phase-2-study-of-its-novel-hifu-therapy-system-for-unresectable-pancreatic-cancer-patients-in-japan/ 2023-02-08T14:12:37+00:00 https://medicaex.com/prnewswire/rnaimmune-mrna-cancer-vaccine-program-accepted-for-oral-presentation-at-the-2023-aacr-annual-meeting/ 2023-02-08T14:12:17+00:00 https://medicaex.com/prnewswire/waterdrop-internally-tests-a-chatgpt-like-application-and-will-apply-it-into-insurance-marketing-and-services/ 2023-02-08T14:12:11+00:00 https://medicaex.com/prnewswire/duoning-headquarters-in-fengxian-biotechnology-park-with-centers-for-rd-and-technology-applications/ 2023-02-08T13:12:22+00:00 https://medicaex.com/prnewswire/syntach-ab-announces-e17-5m-in-blended-funding-names-patrick-nj-schnegelsberg-as-new-ceo-and-appoints-cansel-isikli-as-vp-of-ra-q/ 2023-02-08T13:12:21+00:00 https://medicaex.com/prnewswire/zhongchao-inc-announces-the-application-of-chatgpt-to-elevate-patient-management-service-capabilities-and-experience/ 2023-02-08T13:12:11+00:00 https://medicaex.com/prnewswire/sk-biosciences-zoster-vaccine-receives-biologics-license-application-approval-in-malaysia/ 2023-02-08T12:12:19+00:00 https://medicaex.com/prnewswire/panopticai-secures-fundraising-co-led-by-alibaba-hong-kong-entrepreneurs-fund-and-gobi-partners-gba-to-digitise-remote-healthcare/ 2023-02-07T14:12:23+00:00 https://medicaex.com/prnewswire/bioworld-by-clarivate-rethinks-obesity-in-new-special-investigation-finding-fitness-may-be-more-linked-to-health-than-weight/ 2023-02-07T14:12:19+00:00 https://medicaex.com/prnewswire/esaote-presents-the-world-premiere-of-its-new-mylabx90-ultrasound-device/ 2023-02-07T09:12:31+00:00 https://medicaex.com/prnewswire/healint-announces-a-collaboration-with-university-of-toronto-canada-to-study-the-role-of-pollution-on-migraine/ 2023-02-07T04:12:24+00:00 https://medicaex.com/prnewswire/boehringer-ingelheim-philippines-is-awarded-top-employer-for-the-5th-year-in-a-row/ 2023-02-07T04:12:17+00:00 https://medicaex.com/prnewswire/inaugural-lazada-run-to-add-fitness-to-life-across-southeast-asia/ 2023-02-07T04:12:11+00:00 https://medicaex.com/prnewswire/alma-a-sisram-medical-company-announces-the-launch-of-alma-duo-an-advanced-fda-and-ce-approved-solution-that-promotes-sexual-wellness-for-men-and-women/ 2023-02-07T00:12:22+00:00 https://medicaex.com/prnewswire/breg-partners-with-correal-international-to-provide-orthopedic-products-to-physicians-patients-in-china/ 2023-02-06T23:12:24+00:00 https://medicaex.com/prnewswire/carsgen-announces-collaboration-agreement-to-evaluate-ab011-in-combination-with-pd-l1-checkpoint-inhibitor-to-treat-gastric-cancer/ 2023-02-06T22:14:36+00:00 https://medicaex.com/prnewswire/appendix-4c-q2-fy23-quarterly-cash-flow-report/ 2023-02-06T22:14:36+00:00 https://medicaex.com/prnewswire/cigna-worldwide-insurance-company-receives-branch-license-in-saudi-arabia-plans-growth-in-the-kingdom/ 2023-02-06T15:13:21+00:00 https://medicaex.com/prnewswire/oricell-publishes-data-from-polaris-clinical-study-evaluating-oricar-017-in-the-treatment-of-rrmm-in-the-lancet-haematology/ 2023-02-06T13:12:29+00:00 https://medicaex.com/prnewswire/marc-andre-pepin-of-invescap-announces-significant-expansion-of-clinic-network/ 2023-02-06T13:12:19+00:00 https://medicaex.com/prnewswire/bristar-immunotech-to-present-at-the-bio-ceo-investor-conference/ 2023-02-06T10:12:23+00:00 https://medicaex.com/prnewswire/cgtn-tcm-continues-to-play-significant-role-in-treating-covid-19/ 2023-02-06T10:12:12+00:00 https://medicaex.com/prnewswire/servier-full-year-2021-22-results-confirm-the-transformation-trajectory-of-the-group/ 2023-02-06T08:12:18+00:00 https://medicaex.com/prnewswire/stemline-therapeutics-a-subsidiary-of-menarini-group-receives-u-s-fda-approval-for-orserdutm-elacestrant-as-the-first-and-only-treatment-specifically-indicated-for-patients-with-esr1-mutations-in/ 2023-02-06T05:12:23+00:00 https://medicaex.com/prnewswire/chula-medicine-reveals-detection-of-latent-dementia/ 2023-02-06T05:12:23+00:00 https://medicaex.com/prnewswire/invivoscribe-appoints-masato-sasaki-as-general-manager-of-labpmm-gk-japan/ 2023-02-06T00:12:19+00:00 https://medicaex.com/prnewswire/health-equity-report-card-pilot-project-to-help-close-the-care-gap-highlighted-on-world-cancer-day/ 2023-02-04T14:12:09+00:00 https://medicaex.com/prnewswire/treadwell-therapeutics-announces-the-appointment-of-roger-sidhu-m-d-as-chief-medical-officer/ 2023-02-03T15:12:16+00:00 https://medicaex.com/prnewswire/alpha-biopharma-submits-new-drug-application-for-zorifertinib-a-next-generation-egfr-tki-to-treat-egfr-mutated-nsclc-patients-with-cns-metastases/ 2023-02-03T12:12:28+00:00 https://medicaex.com/prnewswire/hummingbird-bioscience-and-synaffix-enter-license-agreement-to-develop-a-next-generation-antibody-drug-conjugate-adc-program/ 2023-02-03T12:12:23+00:00 https://medicaex.com/prnewswire/medalliance-leads-us-sirolimus-deb-race-first-us-patient-enrolled-into-selution-slr-coronary-sirolimus-deb-study/ 2023-02-03T06:12:25+00:00 https://medicaex.com/prnewswire/hanall-biopharma-reports-full-year-2022-results-and-provides-business-update/ 2023-02-03T06:12:18+00:00 https://medicaex.com/prnewswire/global-times-connected-in-recognition-foreign-ambassadors-signal-a-welcome-for-chinas-optimized-responsible-covid-policy/ 2023-02-03T06:12:15+00:00 https://medicaex.com/prnewswire/ferronova-secures-a11-million-to-advance-nanotech-image-guided-cancer-therapy/ 2023-02-02T15:12:29+00:00 https://medicaex.com/prnewswire/sirnaomics-accelerates-clinical-development-of-stp705-for-the-treatment-of-non-melanoma-skin-cancers/ 2023-02-02T15:12:23+00:00 https://medicaex.com/prnewswire/discgenics-announces-positive-two-year-clinical-data-from-u-s-study-of-discogenic-progenitor-cell-therapy-for-degenerative-disc-disease/ 2023-02-02T06:12:29+00:00 https://medicaex.com/prnewswire/accelerating-energy-efficiency-adoption-deep-tech-startup-krosslinker-develops-a-cost-effective-aerogel-insulation/ 2023-02-02T03:12:15+00:00 https://medicaex.com/prnewswire/totalenergies-eneos-signs-solar-rooftop-project-with-ecolite-a-health-and-wellness-company-in-malaysia/ 2023-02-02T03:12:10+00:00 https://medicaex.com/prnewswire/zhongchao-inc-announces-introduction-of-indian-anti-influenza-drugs-to-china/ 2023-02-02T02:12:20+00:00 https://medicaex.com/prnewswire/cn-energy-group-inc-announces-closing-of-10-million-underwritten-public-offering/ 2023-02-01T16:12:11+00:00 https://medicaex.com/prnewswire/carsgen-presents-results-on-anti-claudin18-2-mab-ab011-at-asco-gi/ 2023-02-01T14:12:26+00:00 https://medicaex.com/prnewswire/prenetics-announces-dr-bayju-thakar-as-chief-executive-officer-of-prenetics-emea/ 2023-02-01T14:12:23+00:00 https://medicaex.com/prnewswire/delivery-of-170000-bottles-of-azvudine-tablets-during-spring-festival-to-help-rural-areas-weather-the-epidemic/ 2023-02-01T14:12:19+00:00 https://medicaex.com/prnewswire/global-times-zhang-wenhong-phenomenon-shows-inclusiveness-of-chinas-public-opinion-sphere-policymaking-based-on-science-helps-nation-firmly-hold-strategic-initiative-of-epidemic-fight/ 2023-02-01T14:12:16+00:00 https://medicaex.com/prnewswire/cbc-group-appoints-chief-operating-officer-strengthening-the-firms-global-operational-capabilities/ 2023-02-01T13:12:11+00:00 https://medicaex.com/prnewswire/singleron-to-present-single-cell-sequencing-solutions-at-the-36th-molecular-biology-of-plants-conference/ 2023-02-01T12:12:21+00:00 https://medicaex.com/prnewswire/cgtn-china-downgrades-covid-19-rules-as-nation-readies-for-normal-life/ 2023-01-31T14:12:15+00:00 https://medicaex.com/prnewswire/bristar-immunotech-to-present-its-novel-cell-therapy-for-acute-myeloid-leukemia-at-the-aacr-special-conference-on-aml-and-mds/ 2023-01-31T13:12:23+00:00 https://medicaex.com/prnewswire/tigermed-completes-acquisition-of-marti-farm/ 2023-01-31T13:12:20+00:00 https://medicaex.com/prnewswire/cgtn-chinas-preparedness-for-adjusting-its-covid-19-policies/ 2023-01-31T13:12:14+00:00 https://medicaex.com/prnewswire/global-times-china-shifts-covid-policy-with-necessary-conditions/ 2023-01-31T13:12:14+00:00 https://medicaex.com/prnewswire/new-therapy-to-treat-rare-gastrointestinal-stromal-tumour-approved-for-new-zealand-patients/ 2023-01-31T12:12:21+00:00 https://medicaex.com/prnewswire/health-in-tech-to-attend-health-care-administration-association-hcaa-executive-forum-2023-as-corporate-sponsor/ 2023-01-31T12:12:13+00:00 https://medicaex.com/prnewswire/axa-designated-endoscopy-and-day-surgery-centre-officially-unveils/ 2023-01-31T11:12:09+00:00 https://medicaex.com/prnewswire/ascletis-announces-u-s-fda-approval-of-conducting-a-phase-iia-clinical-trial-for-asc10-to-treat-respiratory-syncytial-virus-infection/ 2023-01-31T10:12:17+00:00 https://medicaex.com/prnewswire/daewoong-enters-exclusive-licensing-agreement-with-cs-pharmaceuticals-for-bersiporocin-in-idiopathic-pulmonary-fibrosis-in-the-greater-china-region/ 2023-01-31T07:12:13+00:00 https://medicaex.com/prnewswire/abbisko-therapeutics-announces-that-us-fda-has-granted-breakthrough-therapy-designation-for-its-csf-1r-inhibitor-pimicotinib%ef%bc%88absk021%ef%bc%89/ 2023-01-31T06:12:12+00:00 https://medicaex.com/prnewswire/pm-international-donates-e1872000-to-charity-sponsoring-5200-children-around-the-world/ 2023-01-31T03:12:24+00:00 https://medicaex.com/prnewswire/hepagene-therapeutics-reports-positive-top-line-results-for-phase-2a-rise-study-of-fxr-agonist-hpg1860-in-patients-with-nash/ 2023-01-31T01:12:22+00:00 https://medicaex.com/prnewswire/sciwind-biosciences-announces-initiation-of-patient-dosing-in-phase-3-clinical-trials-of-ecnoglutide-xw003-a-long-acting-glp-1-analog-for-the-treatment-of-type-2-diabetes-in-china/ 2023-01-31T01:12:13+00:00 https://medicaex.com/prnewswire/lunit-highlights-the-effectiveness-of-ai-in-predicting-cancer-treatment-outcomes-findings-to-be-presented-at-asco-gi-2023/ 2023-01-30T21:12:22+00:00 https://medicaex.com/prnewswire/healthcare-ai-firm-qritive-raises-7-5m-to-expand-into-new-markets/ 2023-01-30T21:12:19+00:00 https://medicaex.com/prnewswire/profoundbio-announces-initiation-of-first-in-human-trial-for-pro1184-a-folate-receptor-alpha-directed-adc-with-a-topoisomerase-1-inhibitor-payload-and-receives-fda-study-may-proceed-letter-for-p/ 2023-01-30T15:12:19+00:00 https://medicaex.com/prnewswire/samsung-biologics-reports-fourth-quarter-fiscal-year-2022-financial-results/ 2023-01-30T15:12:17+00:00 https://medicaex.com/prnewswire/discgenics-announces-fda-regenerative-medicine-advanced-therapy-rmat-designation-granted-to-idct-for-degenerative-disc-disease/ 2023-01-30T13:12:16+00:00 https://medicaex.com/prnewswire/natus-medical-incorporated-announces-closing-of-acquisition-of-micromed-holding-sas/ 2023-01-30T10:12:19+00:00 https://medicaex.com/prnewswire/asg-superconductors-and-siemens-healthineers-join-forces-to-deliver-10-5t-ultra-high-field-mri-systems-for-ground-breaking-brain-research/ 2023-01-30T03:12:20+00:00 https://medicaex.com/prnewswire/akeso-received-first-tranche-of-us300-million-upfront-payment-from-summit-summit-is-accelerating-clinical-development-of-ivonescimab/ 2023-01-30T03:12:14+00:00 https://medicaex.com/prnewswire/keymed-biosciences-the-latest-results-from-the-phase-ia-clinical-study-of-cmg901-was-presented-at-the-2023-asco-gi-cancers-symposium/ 2023-01-30T02:12:22+00:00 https://medicaex.com/prnewswire/who-goodwill-ambassador-for-leprosy-elimination-has-audience-with-pope-francis/ 2023-01-27T15:12:09+00:00 https://medicaex.com/prnewswire/sn-bioscience-and-boryung-announce-the-licensing-agreement-on-generic-version-of-abraxane/ 2023-01-27T06:12:14+00:00 https://medicaex.com/prnewswire/pfizer-launches-af-journey-website-to-improve-atrial-fibrillation-health-literacy/ 2023-01-27T02:12:13+00:00